1. Epilepsia Partialis Continua as a manifestation of aquaporin-4 autoimmunity.
- Author
-
Romozzi M, Vollono C, Calabresi P, and Iorio R
- Subjects
- Humans, Male, Middle Aged, Autoantibodies blood, Autoantibodies immunology, Autoimmunity, Aquaporin 4 immunology, Epilepsia Partialis Continua etiology, Epilepsia Partialis Continua drug therapy, Epilepsia Partialis Continua diagnostic imaging, Neuromyelitis Optica immunology, Neuromyelitis Optica complications, Neuromyelitis Optica diagnostic imaging, Neuromyelitis Optica drug therapy
- Abstract
A 52-year-old man experienced two seizures in January and June 2021. In October, the neurological examination did not reveal sensory/motor deficits. Brain magnetic resonance imaging (MRI) showed hyperintense lesions with contrast enhancement (CE) involving white matter bilaterally, brainstem, and cerebellum. Spine MRI showed hyperintense C2-C3 and C4-C6 lesions with CE. Anti-aquaporin-4 (AQP4) antibodies were detected, confirming the diagnosis of neuromyelitis optica spectrum disorder (NMOSD). The patient experienced a status epilepticus compatible with Epilepsia Partialis Continua treated with antiseizure medications. He was also treated with methylprednisolone, plasma exchange, and rituximab. Status epilepticus can be a rare manifestation of NMOSD, heightening the broad spectrum of AQP4 autoimmunity., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF